Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic : long-term survival and safety analysis of a phase 3 studyBRAF: long-term survival and safety analysis of a phase 3 study V600E/K-mutant melanoma: long-term survival and safety analysis of a phase 3 study

    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.

Related Topics

    loading  Loading Related Articles